Cornell Engineers Develop Nanoparticle Platform to Deliver Antibodies for Cancer and Inflammation Treatment
Cornell University engineers have developed a groundbreaking nanoparticle platform that can deliver therapeutic antibodies directly into cells, offering a promising approach to treating cancer and inflammation. This innovative technology, which utilizes lipid nanoparticles, has shown remarkable success in various disease models, including cancer, lung inflammation, and Parkinson's disease.
The key to this advancement lies in the cloaking technique, where proteins are modified with a negatively charged ion, allowing them to electrostatically bind to positively charged lipid nanoparticles. This enables the nanoparticles to smuggle their cargo into living cells, where the proteins can exert their therapeutic effects. The Cornell team's cloaking technology, known as SL4, has been successfully applied to deliver anti-alpha-synuclein antibodies for Parkinson's disease treatment.
One of the most exciting aspects of this research is its broad applicability. The team demonstrated the platform's versatility by applying it to two different clinical indications: one in the brain and one in the lungs. By using commercial anti-NF-kB antibodies, they showed improved delivery in the brain and therapeutic benefit in the lungs, showcasing the platform's potential for treating a wide range of diseases.
The success of this technology is not limited to the lab; it has been independently reproduced by researchers in a different country, further solidifying its potential for clinical translation. The Cornell team's approach of sharing their material and protocol with other researchers has led to exciting collaborations and has accelerated the development of this platform technology.
Looking ahead, the researchers are exploring alternative cloaking groups and have launched their own company, Cloak Bio, to pursue additional therapeutic avenues. This development marks a significant step forward in the field of nanotechnology and holds great promise for the future of medicine, offering a more targeted and effective approach to treating various diseases.
